XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net product sales $ 528,295 $ 399,356 $ 329,233
Cost of goods sold 52,943 37,326 38,599
Gross profit 475,352 362,030 290,634
Operating expenses:      
Research and development 109,362 152,381 276,677
Selling, general, and administrative 323,379 275,270 213,041
Changes in fair value of contingent consideration payable 0 2,583 1,078
Loss on impairment of assets 0 1,134 6,616
Restructuring charges 9,188 0 0
Depreciation and amortization 8,547 7,873 5,342
Total operating expenses 450,476 439,241 502,754
Income (loss) from operations 24,876 (77,211) (212,120)
Other (expense) income:      
Interest income 5,407 7,078 3,024
Interest expense (49,598) (50,149) (37,119)
Loss on extinguishment of debt 0 (13,933) 0
Other (expense) income (9,441) (15,886) 4,176
Loss before income tax (28,756) (150,101) (242,039)
Income tax (expense) benefit (27,350) (1,483) 5,471
Net loss attributable to common stockholders $ (56,106) $ (151,584) $ (236,568)
Net loss attributable to common stockholders per common share - basic (in dollars per share) $ (0.18) $ (0.51) $ (0.82)
Net loss attributable to common stockholders per common share - diluted (in dollars per share) $ (0.18) $ (0.51) $ (0.82)
Weighted-average common shares outstanding - basic (in shares) 304,380,502 295,164,515 289,057,198
Weighted-average common shares outstanding - diluted (in shares) 304,380,502 295,164,515 289,057,198